<code id='D25B1500C8'></code><style id='D25B1500C8'></style>
    • <acronym id='D25B1500C8'></acronym>
      <center id='D25B1500C8'><center id='D25B1500C8'><tfoot id='D25B1500C8'></tfoot></center><abbr id='D25B1500C8'><dir id='D25B1500C8'><tfoot id='D25B1500C8'></tfoot><noframes id='D25B1500C8'>

    • <optgroup id='D25B1500C8'><strike id='D25B1500C8'><sup id='D25B1500C8'></sup></strike><code id='D25B1500C8'></code></optgroup>
        1. <b id='D25B1500C8'><label id='D25B1500C8'><select id='D25B1500C8'><dt id='D25B1500C8'><span id='D25B1500C8'></span></dt></select></label></b><u id='D25B1500C8'></u>
          <i id='D25B1500C8'><strike id='D25B1500C8'><tt id='D25B1500C8'><pre id='D25B1500C8'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:fashion    Page View:7
          Senate health committee Chair Bernie Sanders
          Sen. Berne Sanders (I-Vt.) Kevin Dietsch/Getty Images

          WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry.

          Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.

          advertisement

          But the food industry received more attention, especially from Sanders, than the drugmakers and drug middlemen.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Tori Bowie and the unacceptable rates of Black maternal death
          Tori Bowie and the unacceptable rates of Black maternal death

          AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

          read more
          Oral obesity drug from Viking Therapeutics hits key early target
          Oral obesity drug from Viking Therapeutics hits key early target

          DrewAngerer/GettyImagesVikingTherapeuticssaidTuesdaythatitscloselywatchedoralobesitydrughadsucceeded

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Readout LOUD: Venture capital, Gilead, and more M&A

          AreventurecapitalistsOK?Arebolt-onsgoodforbusiness?Andwhenisitsafetosaysomeoneoverpaid?Wecoveralltha